These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 18162525)

  • 1. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
    Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
    Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).
    Rowe PS; Garrett IR; Schwarz PM; Carnes DL; Lafer EM; Mundy GR; Gutierrez GE
    Bone; 2005 Jan; 36(1):33-46. PubMed ID: 15664000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPR4-peptide alters bone metabolism of normal and HYP mice.
    Zelenchuk LV; Hedge AM; Rowe PS
    Bone; 2015 Mar; 72():23-33. PubMed ID: 25460577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
    Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
    J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.
    Boukpessi T; Gaucher C; Léger T; Salmon B; Le Faouder J; Willig C; Rowe PS; Garabédian M; Meilhac O; Chaussain C
    Am J Pathol; 2010 Aug; 177(2):803-12. PubMed ID: 20581062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism.
    Zelenchuk LV; Hedge AM; Rowe PS
    PLoS One; 2014; 9(5):e97326. PubMed ID: 24839967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
    Addison WN; Nakano Y; Loisel T; Crine P; McKee MD
    J Bone Miner Res; 2008 Oct; 23(10):1638-49. PubMed ID: 18597632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do ASARM peptides play a role in nephrogenic systemic fibrosis?
    Rowe PS; Zelenchuk LV; Laurence JS; Lee P; Brooks WM; McCarthy ET
    Am J Physiol Renal Physiol; 2015 Nov; 309(9):F764-9. PubMed ID: 26336161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
    Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
    J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.
    David V; Martin A; Hedge AM; Drezner MK; Rowe PS
    Am J Physiol Renal Physiol; 2011 Mar; 300(3):F783-91. PubMed ID: 21177780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage.
    Addison WN; Masica DL; Gray JJ; McKee MD
    J Bone Miner Res; 2010 Apr; 25(4):695-705. PubMed ID: 19775205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active sites of human MEPE-ASARM regulating bone matrix mineralization.
    Minamizaki T; Sakurai K; Hayashi I; Toshishige M; Yoshioka H; Kozai K; Yoshiko Y
    Mol Cell Endocrinol; 2020 Nov; 517():110931. PubMed ID: 32712387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.
    Rowe PS
    Cell Biochem Funct; 2012 Jul; 30(5):355-75. PubMed ID: 22573484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia.
    Salmon B; Bardet C; Khaddam M; Naji J; Coyac BR; Baroukh B; Letourneur F; Lesieur J; Decup F; Le Denmat D; Nicoletti A; Poliard A; Rowe PS; Huet E; Vital SO; Linglart A; McKee MD; Chaussain C
    PLoS One; 2013; 8(2):e56749. PubMed ID: 23451077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif.
    Zelenchuk LV; Hedge AM; Rowe PS
    Bone; 2015 Oct; 79():131-42. PubMed ID: 26051469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth.
    Salmon B; Bardet C; Coyac BR; Baroukh B; Naji J; Rowe PS; Opsahl Vital S; Linglart A; Mckee MD; Chaussain C
    Connect Tissue Res; 2014 Aug; 55 Suppl 1():79-82. PubMed ID: 25158186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
    Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
    J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.
    Rowe PS; Matsumoto N; Jo OD; Shih RN; Oconnor J; Roudier MP; Bain S; Liu S; Harrison J; Yanagawa N
    Bone; 2006 Oct; 39(4):773-86. PubMed ID: 16762607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
    Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
    Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.